Synopsys CEO Ghazi Sassine sells 14,604 shares

The reported sale price is a weighted average across transactions priced between $455.060 and $471.325 per share.

Rhea-AI Filing Summary

Synopsys (SNPS) President and CEO Ghazi Sassine exercised non-qualified stock options for 14,604 shares on October 15, 2026, at an exercise price of $135.8800 per share, acquiring 14,604 common shares. He sold 14,604 common shares that day at a weighted average price of $462.8430 per share; the sale transactions ranged from $455.060 to $471.325 per share. The transactions were effected under a Rule 10b5-1 trading plan adopted September 19, 2025.

Insider Trade Summary 10b5-1

Exercise and Sale: 14,604 shares ($4.77M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Ghazi Sassine

Role PRESIDENT AND CEO

Sold 14,604 shs ($6.76M)

Approx. gross sale proceeds $6.76M

Approx. exercise cost $1.98M

Approx. pre-tax spread $4.77M

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy) F2	14,604	$0.00	$0.00
Exercise	Common Stock	14,604	$135.88	$1.98M
Sale	Common Stock F1	14,604	$462.843	$6.76M

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 76,865 shares (Direct)

Footnotes (2)

1. F1. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $455.060 to $471.325. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
2. F2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025.

Key Figures

Options exercised: 14,604 shares Exercise price: $135.8800 per share Common shares sold: 14,604 shares +2 more

5 metrics

Options exercised 14,604 shares October 15, 2026

Exercise price $135.8800 per share Non-qualified stock options exercised October 15, 2026

Common shares sold 14,604 shares October 15, 2026

Weighted average sale price $462.8430 per share Sale on October 15, 2026

Sale price range $455.060 to $471.325 per share Multiple sale transactions

Key Terms

Non-Qualified Stock Option, Rule 10b5-1 trading plan, weighted average sale price

3 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

Rule 10b5-1 trading plan regulatory

"effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"Represents a weighted average sale price per share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SNPS shares did CEO Ghazi Sassine sell, and at what price?

Ghazi Sassine sold 14,604 common shares on October 15, 2026, at a weighted average price of $462.8430 per share. The sale transactions ranged from $455.060 to $471.325 per share and were effected under a Rule 10b5-1 trading plan adopted September 19, 2025.

How many Synopsys options did CEO Ghazi Sassine exercise?

Ghazi Sassine exercised 14,604 non-qualified stock options on October 15, 2026, at an exercise price of $135.8800 per share. The exercise resulted in the acquisition of 14,604 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 05:43 PM EDT Accepted by SEC EDGAR 10/16/2026 - 05:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ghazi Sassine

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CALIFORNIA 94085

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2026		M		14,604	A	$135.88	91,469	D
Common Stock	10/15/2026		S		14,604	D	$462.843(1)	76,865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$135.88	10/15/2026		M(2)			14,604	12/12/2020	12/12/2026	Common Stock	14,604	$0.0	0	D

Explanation of Responses:

1. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $455.060 to $471.325. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 19, 2025.

	By: POA pursuant Mary Lai For: Sassine E Ghazi	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)